BioBridgeXAll companies

PolyCore Therapeutics, Inc.

Biotechnology company · Philadelphia, Pennsylvania, United States

PolyCore Therapeutics, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $4.7 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

PolyCore Therapeutics at a glance

Typebiotechnology company
HeadquartersPhiladelphia, Pennsylvania, United States
Earliest incorporation on record2022
Employees (self-reported, 2020)2
SEC CIK1914733

What does PolyCore Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $4.7 million sold (2022).

Frequently asked questions about PolyCore Therapeutics

Where is PolyCore Therapeutics headquartered?

PolyCore Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does PolyCore Therapeutics do?

PolyCore Therapeutics, Inc. is a biotechnology company.

When was PolyCore Therapeutics founded?

The earliest incorporation on record for PolyCore Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences